SMARTER SUPPLY CHAINS. STRONGER BUSINESS.
Supply Chain Partners — Connecting People, Process, Technology

SCP Insights / Industry comparison / Cold chains

What happens when a cold-chain exception occurs?

Food and pharmaceutical flows can share event data while requiring different evidence, decisions and release controls.

← All insights
Illustrative freight trucks travelling between logistics facilities.
Each transport handover needs a clear link between the shipment, its condition records and the next decision.

Detection starts a decision process

A temperature alert is useful when the team knows which goods it concerns, where they are and what action is authorised. A missing sensor reading is a different exception from a confirmed excursion. Neither should disappear into a green dashboard because a vehicle arrived on time.

This comparison considers food and temperature-sensitive pharmaceutical flows. It does not assume that all products in either sector require refrigeration, share the same temperature range or follow the same release process.

What the guidance says

WHO’s 2011 model guidance addresses storage and distribution of time- and temperature-sensitive pharmaceuticals, while recognising that local legislation takes precedence. It includes receiving, quarantine and transport controls. It provides a foundation for examining the operating process, not a substitute for current product-specific instructions or qualified quality decisions. [1]

FDA’s US sanitary transportation overview addresses conditions such as suitable equipment, temperature control and contamination prevention for covered food transport. Its scope and exemptions matter. Food safety, product quality and remaining shelf life should be examined explicitly rather than treated as interchangeable measures. [2]

Traceability is a related but distinct requirement. FDA’s Food Traceability Rule links key data elements to critical tracking events for covered foods. Its DSCSA FAQ recommends EPCIS for interoperable electronic exchange in the relevant pharmaceutical distribution context. These are different US frameworks, not a single global rule or a common cold-chain certification. Product scope, exemptions and current implementation policies require separate assessment. [3][4]

Compare the response, not just the sensor

This is SCP’s proposed operating comparison; the actual procedure must follow the product, jurisdiction and accountable quality function.

Decision lensFood flowPharmaceutical flow
Evidence boundaryRelevant lot, handling history, condition and intended useRelevant product identity, condition history and applicable quality records
Immediate responseIdentify affected stock and follow the agreed safety/quality hold processIdentify affected stock and follow the applicable controlled hold process
DispositionAuthorised assessment of safety, quality and permitted next stepsAuthorised quality assessment under applicable product and distribution controls
Service consequenceReplenishment, fulfilment and waste implications after dispositionSupply continuity and customer commitments after disposition

Use shared events without losing the underlying evidence

GS1’s March 2023 EPCIS implementation guideline includes sensor-based quality examples and business-oriented summaries of measurements, with references to underlying data where needed. That offers a way to exchange useful condition information alongside business events. It does not prove a sensor was calibrated, a reading represented the product’s condition or a shipment is suitable for release. [5]

Our proposed Control Tower workflow connects the lot or item, shipment, custody handover, condition record and affected order. It then assigns an owner, records the hold or escalation and preserves the authorised disposition. Operational traceability belongs within this workflow; blockchain is not assumed to be necessary.

Measure response quality as well as speed

For a pilot, choose one product flow and agree its procedure with the responsible quality specialists. Test missing data, a confirmed excursion and a delayed handover separately. Do not introduce generic temperature limits or automate release because a logistics milestone is complete.

  • Track the share of shipments with complete linked evidence, including missing-reading exceptions.
  • Measure time from detection to acknowledgement, controlled hold and authorised disposition.
  • Record incorrect alerts, missed exceptions, resupply actions and service consequences.
  • Compare waste and expediting costs only after product mix and the approved disposition are understood.

Start with a workflow that can be tested

SCP could help map the exception process, data links and operating responsibilities, then design a supervised trial. Product stability, food safety, regulatory interpretation and release authority remain with appropriately qualified people. The workshop would establish the boundary before any technology or benefit commitment.

Sources and evidence notes

Sources checked on 17 October 2026. Research findings and company reports are attributed above; practical recommendations are SCP’s interpretation. The examples do not imply endorsement, partnership or SCP client results.

  1. WHO TRS 961, Annex 9: Model guidance for storage and transport of time- and temperature-sensitive pharmaceutical products ↗

    2 August 2011. International technical guidance; relevant receiving, quarantine and transport provisions reviewed; local requirements take precedence.

  2. FDA: FSMA sanitary transportation rule ↗

    2016 rule; current publisher overview checked 17 October 2026. US regulatory overview; scope and exemptions apply.

  3. FDA: Food Traceability Rule ↗

    2022 final rule; current overview checked 17 October 2026. US traceability recordkeeping overview for covered foods and activities; not a universal temperature standard.

  4. FDA: DSCSA product tracing requirements — frequently asked questions ↗

    Undated FAQ; checked 17 October 2026. US agency interpretation; relevant drug/product and trading-partner scope applies.

  5. GS1 EPCIS and CBV Implementation Guideline 2.0 ↗

    March 2023. Standards implementation guidance; sensor-data examples in section 5.11 reviewed; not evidence of a particular deployment.

Explore the industries and services

Explore the next step

Bring a recent condition or missing-data exception, the product flow, available records and the approved escalation procedure. Include quality, operations, logistics, data owners and any required specialists.

Explore a Transport Reliability Discovery Workshop →

Workshop format and any fees are agreed before booking. Follow-on work requires a separate scope and business agreement.